GW Pharmaceuticals Reports 2013 Q4 And Full Year Financial Results
11/19/2013 6:12:45 AM
LONDON, Nov. 19, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announces its preliminary results for the fourth quarter and the year ended 30 September 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by